JP2002513399A - 医学治療に有用なテルベンゾイミダゾール（トポイソメラーゼインヒビター） - Google Patents

医学治療に有用なテルベンゾイミダゾール（トポイソメラーゼインヒビター）

Info

Publication number
JP2002513399A
JP2002513399A JP53462498A JP53462498A JP2002513399A JP 2002513399 A JP2002513399 A JP 2002513399A JP 53462498 A JP53462498 A JP 53462498A JP 53462498 A JP53462498 A JP 53462498A JP 2002513399 A JP2002513399 A JP 2002513399A
Authority
JP
Japan
Prior art keywords
alkyl
halogen
halo
compound
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP53462498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002513399A5 (enExample
Inventor
ジェイ． ラボイエ，エドモンド
フォング リウ，リロイ
ソン，クン
Original Assignee
ルトガーズ，ザ ステイト ユニバーシティ オブ ニュージャージー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ルトガーズ，ザ ステイト ユニバーシティ オブ ニュージャージー filed Critical ルトガーズ，ザ ステイト ユニバーシティ オブ ニュージャージー
Publication of JP2002513399A publication Critical patent/JP2002513399A/ja
Publication of JP2002513399A5 publication Critical patent/JP2002513399A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP53462498A 1997-01-21 1998-01-21 医学治療に有用なテルベンゾイミダゾール（トポイソメラーゼインヒビター） Ceased JP2002513399A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/786,629 US5770617A (en) 1996-03-20 1997-01-21 Terbenzimidazoles useful as antifungal agents
US08/786,629 1997-01-21
PCT/US1998/001005 WO1998031673A1 (en) 1997-01-21 1998-01-21 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)

Publications (2)

Publication Number Publication Date
JP2002513399A true JP2002513399A (ja) 2002-05-08
JP2002513399A5 JP2002513399A5 (enExample) 2005-09-08

Family

ID=25139154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53462498A Ceased JP2002513399A (ja) 1997-01-21 1998-01-21 医学治療に有用なテルベンゾイミダゾール（トポイソメラーゼインヒビター）

Country Status (10)

Country Link
US (1) US5770617A (enExample)
EP (1) EP0960103A1 (enExample)
JP (1) JP2002513399A (enExample)
KR (1) KR20000070359A (enExample)
AU (1) AU746663B2 (enExample)
CA (1) CA2278452A1 (enExample)
IL (1) IL130572A0 (enExample)
NZ (1) NZ336606A (enExample)
PL (1) PL334662A1 (enExample)
WO (1) WO1998031673A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013527220A (ja) * 2010-06-01 2013-06-27 サミット コーポレイション ピーエルシー クロストリジウム・ディフィシル関連疾患を治療するための化合物
US9763925B2 (en) 2008-12-02 2017-09-19 Summit Therapeutics Plc Antibacterial compounds

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299358A (zh) * 1997-12-31 2001-06-13 新泽西州州立大学(拉特格斯) 杂环拓扑异构酶毒性剂
IL137351A0 (en) 1998-02-12 2001-07-24 Univ Rutgers Heterocyclic topoisomerase poisons
WO2000076556A2 (en) * 1999-06-11 2000-12-21 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6740650B2 (en) 1999-10-29 2004-05-25 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
JP2004536034A (ja) 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
AU2002363658B2 (en) * 2001-11-14 2008-09-11 Rutgers, The State University Solubilized topoisomerase poisons
CA2467279A1 (en) * 2001-11-14 2003-06-26 Edmond J. Lavoie Solubilized topoisomerase poison agents
ATE405568T1 (de) * 2001-11-14 2008-09-15 Univ Rutgers Cytotoxische mittel
DE60225943T2 (de) * 2001-11-14 2009-01-29 Rutgers, The State University Topoisomerase-giftmittel
EP1458416A1 (en) 2001-12-13 2004-09-22 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
AU2003268075A1 (en) * 2002-08-09 2004-02-25 Edmond J. Lavoie Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
US6992088B2 (en) * 2002-08-09 2006-01-31 Rutgers, The State University Of New Jersey Nitro and amino substituted heterocycles as topoisomerase I targeting agents
US6989387B2 (en) * 2002-08-09 2006-01-24 Rutgers, The State University Of New Jersey Nitro and amino substituted topoisomerase agents
AU2003290818A1 (en) * 2002-11-12 2004-06-03 Edmond J. Lavoie Topoisomerase-targeting agents
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
JP5773888B2 (ja) 2009-03-06 2015-09-02 ラットガーズ，ザ・ステート・ユニバーシティ・オブ・ニュージャージー 癌治療に用いられるメチレンジオキシベンゾ［ｉ］フェナントリジン誘導体
WO2010127363A1 (en) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Toposiomerase inhibitors
US9920014B2 (en) 2013-09-19 2018-03-20 The Florida International University Board Of Trustees Selective inhibition of bacterial topoisomerase I
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
CA3011672C (en) 2016-01-23 2022-11-01 Vibha Tandon Broad spectrum antibacterial activity of bisbenzimidazoles targeting topoisomerase ia
EP3442979A4 (en) 2016-04-04 2019-12-18 Rutgers, the State University of New Jersey topoisomerase poisons
JP7267563B2 (ja) 2017-06-27 2023-05-02 株式会社Kyulux 発光材料、化合物、遅延蛍光体および発光素子
WO2019004254A1 (ja) 2017-06-27 2019-01-03 株式会社Ｋｙｕｌｕｘ 発光材料、化合物、遅延蛍光体および発光素子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2221248A1 (en) * 1995-05-17 1996-11-21 Leroy Fong Liu Tribenzimidazoles useful as topoisomerase i inhibitors
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9763925B2 (en) 2008-12-02 2017-09-19 Summit Therapeutics Plc Antibacterial compounds
JP2013527220A (ja) * 2010-06-01 2013-06-27 サミット コーポレイション ピーエルシー クロストリジウム・ディフィシル関連疾患を治療するための化合物
JP2015214541A (ja) * 2010-06-01 2015-12-03 サミット コーポレイション ピーエルシーＳｕｍｍｉｔ Ｃｏｒｐｏｒａｔｉｏｎ Ｐｌｃ クロストリジウム・ディフィシル関連疾患を治療するための化合物

Also Published As

Publication number Publication date
NZ336606A (en) 2001-04-27
PL334662A1 (en) 2000-03-13
IL130572A0 (en) 2000-06-01
AU746663B2 (en) 2002-05-02
CA2278452A1 (en) 1998-07-23
AU6132798A (en) 1998-08-07
US5770617A (en) 1998-06-23
EP0960103A1 (en) 1999-12-01
KR20000070359A (ko) 2000-11-25
WO1998031673A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
US5770617A (en) Terbenzimidazoles useful as antifungal agents
WO1998031673A9 (en) Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)
Sun et al. Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors
DE69705112T2 (de) Coralynanaloge als topoisomerase inhibitoren
EP2464232B1 (en) Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
US5807874A (en) Trisbenzimidazoles useful as topoisomerase I inhibitors
CA2316223A1 (en) Hydrophilic coating for an intracorporeal medical device
JPH11508229A (ja) トポイソメラーゼインヒビターとして有用なトリスベンズイミダゾール類
AU753268B2 (en) Heterocyclic topoisomerase poisons
JP2002503653A (ja) 複素環式トポイソメラーゼ毒素
WO2023284420A1 (zh) 一种多环芳基化合物在抗真菌药物制备中的应用
CZ258999A3 (cs) Terbenzimidazoly a farmaceutický prostředek
MXPA99006793A (es) Terbencimidazoles utiles para terapia medica(inhibidores de topoisomerasa)
KR102517368B1 (ko) 항진균 활성을 갖는 신규한 이미다졸 유도체의 염 및 이의 용도
JP2000072677A (ja) 抗真菌性組成物
MXPA97008822A (en) Tribencimidazoles useful as inhibitors of topoisomeras
CZ20002965A3 (cs) Benzimidazolové deriváty
MXPA00006499A (en) Heterocyclic topoisomerase poisons
MXPA00007838A (en) Heterocyclic topoisomerase poisons
CZ20002497A3 (cs) Heterocyklické sloučeniny

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081007

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20090217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090421